PUBLICATIONS · 24687829
Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2014 May 1
- First author
- Stockler MR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
- note
- Source null
- related pmid
- 24637996
- relationship
- Comment in
Authors and identifiers
- name
- Stockler MR
- type
- Author
- name
- Hilpert F
- type
- Author
- name
- Friedlander M
- type
- Author
- name
- King MT
- type
- Author
- name
- Wenzel L
- type
- Author
- name
- Lee CK
- type
- Author
- name
- Joly F
- type
- Author
- name
- de Gregorio N
- type
- Author
- name
- Arranz JA
- type
- Author
- name
- Mirza MR
- type
- Author
- name
- Sorio R
- type
- Author
- name
- Freudensprung U
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stockler MR
- type
- Author
- name
- Hilpert F
- type
- Author
- name
- Friedlander M
- type
- Author
- name
- King MT
- type
- Author
- name
- Wenzel L
- type
- Author
- name
- Lee CK
- type
- Author
- name
- Joly F
- type
- Author
- name
- de Gregorio N
- type
- Author
- name
- Arranz JA
- type
- Author
- name
- Mirza MR
- type
- Author
- name
- Sorio R
- type
- Author
- name
- Freudensprung U
- type
- Author
- bibliography ids
- nci-bib-23d54d232287b7f3fd8f17c4
- book metadata
- content sha256
- 361f11bccbf53e4be9cfd7bf1f11f508482db1733b4453f38ca53014358bd18b
- document type
- citation
- dois
- 10.1200/JCO.2013.51.4240
- electronic publication date
- display
- 2014 Mar 31
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:24687829
- immutable id
- pubmed:24687829@361f11bccbf53e4be9cfd7bf1f11f508482db1733b4453f38ca53014358bd18b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 13
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1309-16
- volume
- 32
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2014 May 1;32(13):1287-9. doi: 10.1200/JCO.2013.54.7299.
- note
- Source null
- related pmid
- 24637996
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 24687829
- provenance
- batch id
- 063b6c38419f18d4021f
- provider
- NCBI PubMed ESummary
- record sha256
- a405a01e1a239c5f2793b9727405ae2d1b06dc4313ba19254fe5451d744780e6
- response sha256
- 5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
- retrieved at
- 2026-09-09T23:47:02.607425+00:00
- publication date
- display
- 2014 May 1
- precision
- day
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
Preserved source evidence · Not medical advice
Triangle